President Donald Trump's administration slashed cancer research funding by 31% in the first three months of 2025 compared to ...

President Donald Trump signed a new executive order this week directing pharmaceutical companies to lower U.S. drug prices to match the costs paid by other countries—a dramatic-sounding move that ...